the anticoagulant reported here was studied by means of a sequential clotting system utilizing crude coagulation factors and was noted to interfere with the action of activated plasma thromboplastin antecedent ( pta ) during the activation of factor ix .
C0005789
coagulation factors
C0015491
factor ix